Health Boards
(Mon-08-09-2014, 23:07 PM)jiml Wrote: That makes some interesting reading it's clear to see which way the major companies are going and it's good to read of the projected increase in use by 2023.
Perhaps by then doctors will stop dishing out steroid creams and methotrexate so readily .
It's good to see the biosimilars are likely to be launched in the next few years, hopefully bringing the cost of treatments down significantly
There NOT really all that cheaper in the U.S. Maybe in the future, but not at launch. There is little to no information on copay assistance cards. Who can afford 2k + USD copay for three months of drug? I know I can't. For those of us that have been downthe anti TNF path, might as well move on to something new.
